From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Expe…

Inhibition of PRMT5 triggers synthetic lethality in ARID1A-deficient endometrial cancer by…

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2065008731891478531

Krüppel-like factor 2 programs early exhausted T cell states and restrains antiviral immun…

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2065008704309735425

Large-scale parallel characterization of RNA-guided nuclease activity and specificity

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2065008724773744643

Reprogramming macrophage immunometabolism via glutamine antagonism potentiates colorectal …

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2072500662350464800

Mitophagy mitigates mitochondrial DNA-induced activation of cGAS-STING in autoimmune thyro…

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2072500662350464839

Reengineered Albumin-Paclitaxel Nanoparticles Remodeling Tumor Cell Death Pathways for Pre…

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2065008720860459009

Photoactivated iridium(III) complexes drive pyroptosis–necroptosis synergy for multi-netwo…

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2072500662350464617

KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to…

Source: Yeasen Biotech·https://www.yeasen.com/literature/detail/2065009772401831938